February 8, 2024 · Form 4 insider transaction
Vazquez Chris bought 17,483 shares of Biodesix, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.; These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.